Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
Growth was broad-based across segments
Pharma giant targets new standards of care
By cutting pain crises & boosting haemoglobin
Revvity is positioning its technologies as a connected engine for discovery
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Beyond clinical trials, real-world evidence is adding weight to AbbVie’s claims
CagriSema produced a 23% weight loss at 84 weeks, versus 25.5% for tirzepatide
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
